Older Migraine Drugs More Effective Than Some Newer Options, Study Finds

Health & Lifestyle
125

Listen to article (english)

Translate to Spanish or other 102 languages!

Many triptans, an older class of migraine drugs, appear to be more effective at pain management than newer, more expensive medications. Image for illustration purposes
Many triptans, an older class of migraine drugs, appear to be more effective at pain management than newer, more expensive medications. Image for illustration purposes

Medical News Today

- Advertisement -
  • Migraine attacks can be painful to experience, and many medications are available to help with treatment.
  • One systematic review and network meta-analysis found that certain triptans may be more effective treatment options than more recently available migraine medications.
  • Findings from this review may be helpful in guiding migraine treatment recommendations.

Finding the right medication to help with migraine attacks can make all the difference in symptom relief. Experts are interested in finding the best medication choices and comparing them.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/older-migraine-drugs-more-effective-than-some-newer-options-study-finds?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Peripheral Artery Disease
Next article
STHS Behavioral:  What To Do in a Mental Health Crisis Free Webinar, Oct. 3rd

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...
- Advertisement -